Literature DB >> 2133058

Association-dissociation processes and supermolecular organisation of the capsule antigen (protein F1) of Yersinia pestis.

E D Vorontsov1, A G Dubichev, L N Serdobintsev, A V Naumov.   

Abstract

The association-dissociation processes involving the capsule antigen of Yersinia pestis were investigated. In aqueous salt solutions the material of the capsule (protein F1) exists in the form of associated species containing identical monomeric protein subunits. Brief heating (100 degrees C, 3 min) of F1 dissolved in buffered salt solutions at pHs between 4.4 and 7.5 leads to dissociation of the antigen into oligomers which reassociate at room temperature into aggregates of high molecular mass. In the presence of 7 M urea and 0.1% SDS such reassociation is suppressed. It is shown that a few seconds after heat treatment the protein exists as the tetramer in phosphate buffer and as the dimer and the monomer in the presence of urea and SDS respectively. Interconversions of these three forms of the antigen were observed on replacement of one buffer by another. The effect of pH, ionic strength, F1 concentration, and temperature on the rate of association of F1 were also investigated. A decrease in pH, an increase in the ionic strength of the solution, and an increase in the concentration of the protein in aqueous buffered salt solutions all accelerate the F1 aggregation process. A model is proposed for the supermolecular structure of the F1 protein associated species in which the subunits are assembled into a single plane containing tens of dimers as a result of lateral interdimer hydrogen bonds. The dimer is stabilised by hydrophobic interactions of the nonpolar sections of the subunits, which in the associated protein form an internal hydrophobic surface analogous to that in lipid bilayer membranes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2133058

Source DB:  PubMed          Journal:  Biomed Sci


  10 in total

1.  Proteomic characterization of Yersinia pestis virulence.

Authors:  Brett A Chromy; Megan W Choi; Gloria A Murphy; Arlene D Gonzales; Chris H Corzett; Brian C Chang; J Patrick Fitch; Sandra L McCutchen-Maloney
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

2.  Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

Authors:  G P Andrews; D G Heath; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.

Authors:  Wei Sun; Shilpa Sanapala; Hannah Rahav; Roy Curtiss
Journal:  Vaccine       Date:  2015-10-26       Impact factor: 3.641

4.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 5.  Yersinia pestis--etiologic agent of plague.

Authors:  R D Perry; J D Fetherston
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis.

Authors:  Yidong Du; Roland Rosqvist; Ake Forsberg
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

7.  Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.

Authors:  Joseph N Brewoo; Tim D Powell; Dan T Stinchcomb; Jorge E Osorio
Journal:  Vaccine       Date:  2010-07-12       Impact factor: 3.641

8.  Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Authors:  Haim Grosfeld; Sara Cohen; Tamar Bino; Yehuda Flashner; Raphael Ber; Emanuelle Mamroud; Chanoch Kronman; Avigdor Shafferman; Baruch Velan
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Biogenesis of the fraction 1 capsule and analysis of the ultrastructure of Yersinia pestis.

Authors:  Lisa M Runco; Selina Myrczek; James B Bliska; David G Thanassi
Journal:  J Bacteriol       Date:  2008-02-29       Impact factor: 3.490

10.  Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis.

Authors:  Weicen Liu; Jun Ren; Jinlong Zhang; Xiaohong Song; Shuling Liu; Xiangyang Chi; Yi Chen; Zhonghua Wen; Jianmin Li; Wei Chen
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.